Back to Search
NILS MERTENS, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1972205441Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (18)
Molecular analysis of cross-reactive anti-myosin/anti-streptococcal mouse monoclonal antibodies.
PMID 11282394·Mol Immunol·2000
7-preclinical
Efficient production of human bivalent and trivalent anti-MUC1 Fab-scFv antibodies in Pichia pastoris.
PMID 19671134·BMC Biotechnol·2009
4-observational
Callosal dysfunction in amyotrophic lateral sclerosis correlates with diffusion tensor imaging of the central motor system.
PMID 18456495·Neuromuscul Disord·2008
3-trial
Biodistribution and planar gamma camera imaging of (123)I- and (131)I-labeled F(ab')(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor.
PMID 17383575·Nucl Med Biol·2007
7-preclinical
Reduced oxidative damage in ALS by high-dose enteral melatonin treatment.
PMID 17014688·J Pineal Res·2006
3-trial
Angiogenesis enhances factor IX delivery and persistence from retrievable human bioengineered muscle implants.
PMID 16750937·Mol Ther·2006
7-preclinical
In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model.
PMID 16243799·Clin Cancer Res·2005
7-preclinical
CD3 x CD28 cross-interacting bispecific antibodies improve tumor cell dependent T-cell activation.
PMID 15891885·Cancer Immunol Immunother·2005
7-preclinical
Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS.
PMID 15568021·Nat Neurosci·2005
7-preclinical
Radiolabeled annexin-V for monitoring treatment response in oncology.
PMID 15186599·Cancer Biother Radiopharm·2004
6-review
New strategies in polypeptide and antibody synthesis: an overview.
PMID 15068618·Cancer Biother Radiopharm·2004
6-review
Optimizing expression and purification from cell culture medium of trispecific recombinant antibody derivatives.
PMID 12651012·J Chromatogr B Analyt Technol Biomed Life Sci·2003
8-other
Expression in Escherichia coli of the death domain of the human p55 tumor necrosis factor receptor.
PMID 11676596·Protein Expr Purif·2001
8-other
A new model for intermediate molecular weight recombinant bispecific and trispecific antibodies by efficient heterodimerization of single chain variable domains through fusion to a Fab-chain.
PMID 11337278·Biomol Eng·2001
7-preclinical
Fab chains as an efficient heterodimerization scaffold for the production of recombinant bispecific and trispecific antibody derivatives.
PMID 11120833·J Immunol·2000
7-preclinical
Efficient heterodimerization of recombinant bi- and trispecific antibodies.
PMID 11105248·Bioseparation·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 300 LONGWOOD AVE, CHILDREN'S HOSPITAL BOSTON
BOSTON, MA 02115 - Phone
- (617) 355-8241
Quick Facts
- NPI
- 1972205441
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 18
Are you this provider?
Claim Your Profile